AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1

Historical Holders from Q3 2024 to Q3 2025

Type / Class
Debt / NOTE 2.000% 3/1
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
298,658,206
Holdings value
$271,682,316
% of all portfolios
0%
Number of holders
44
Number of buys
19
Number of sells
-16
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1

Period Principal Value Change Price Investors
2025 Q3 298,658,206 $271,682,316 +$15,400,429 $0.909 44
2025 Q2 287,504,200 $250,404,674 -$1,633,019 $0.8666 42
2025 Q1 289,012,700 $257,820,283 -$20,287,313 $0.8889 39
2024 Q4 310,090,000 $290,929,251 -$11,267,553 $0.9311 36
2024 Q3 320,190,500 $339,259,650 +$336,118,248 $1.06 35